Login

Financial Snapshot

Revenue
TTM
$48.79M
Gross Margin
TTM
42.47%
Net Income
TTM
-$36.64M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
334.85%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-$15.04M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$14.18M

Stock Price

Loading...
Market Cap: $106 Million

About Charlotte's Web Holdings Inc

Charlotte's Web Holdings (OTC: CWBHF) is a hemp-derived CBD consumer products company that cultivates proprietary hemp genetics, extracts cannabinoids, and sells finished wellness products including oils, capsules, chews, and topicals. The company generates revenue through direct-to-consumer e-commerce and wholesale channels. Incorporated in British Columbia on May 18, 2018 under the name Stanley Brothers Holdings Inc., it is headquartered in Louisville, Colorado. Charlotte's Web controls its supply chain from seed to shelf, growing proprietary hemp varieties across Arizona, Colorado, Kentucky, New Mexico, and Canada, processing biomass via supercritical fluid extraction and alcohol extraction at its own production facility, and packaging finished goods either in-house or at contract manufacturer facilities. The company holds NSF 455-2 current Good Manufacturing Practices certification (obtained 2020) and ISO 17025 laboratory accreditation (obtained January 2022). Charlotte's Web has issued utility patents in the United States and Canada covering proprietary hemp plant varieties including 'LINDOREA', 'KIRSCHE', 'EM15B2A170', and 'CW-676'.

Revenue model
Revenue is transactional, generated through direct-to-consumer e-commerce sales and wholesale distribution of branded hemp-derived CBD products including liquid oils, capsules, chews, and topicals. E-commerce traffic and customer acquisition are driven by advertising and promotional expenditures, making marketing efficiency a direct lever on revenue.
Products and services
Hemp-derived CBD products sold under the Charlotte's Web brand: liquid oils (diluted with medium chain triglycerides from coconut oil or olive oil), softgel capsules, chews, and topical products. Raw materials are processed via supercritical fluid extraction (SFE) and alcohol extraction (AE) from proprietary hemp genetics developed and cultivated internally. All products are tested for cannabinoid potency, residual solvents, heavy metals, and pesticides by internal and third-party laboratories before release.
Customers and end markets
End consumers purchasing hemp-derived CBD wellness products through e-commerce and retail wholesale channels. The company's filings identify e-commerce traffic and new consumer acquisition as primary growth drivers, indicating a direct-to-consumer emphasis. No specific customer concentration data or retail partner names are disclosed in the excerpts provided.
Value-chain role
Vertically integrated from genetics and cultivation through extraction, quality control, finished goods manufacturing, and direct-to-consumer sales. The company maintains title to hemp plants throughout the growing process, operates its own extraction and production facility, and uses contract manufacturers as a supplementary production channel.
Geographic exposure
Hemp cultivation across Arizona, Colorado, Kentucky, New Mexico, and Canada (as of the 10-K filed 2026-03-31). Corporate headquarters in Louisville, Colorado. Incorporated in British Columbia, Canada under the Business Corporations Act.

Source: SEC 10-K, filed 2026-03-31

Industry: Agricultural Production-Crops Peers: Q/C Technologies Inc TherapeuticsMD Inc Anebulo Pharmaceuticals Inc Assertio Holdings Inc Dare Bioscience Inc Hyperion DeFi Inc Johnson & Johnson SCYNEXIS Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support